Lumia is the first wearable Continuous Blood Flow Monitor (CBFM). Just as CGMs transformed diabetes care, Lumia’s wearable Continuous Blood Flow Monitoring technology will transform care for people with blood flow issues. Blood flow issues affect a wide range of chronic cardiovascular conditions, from orthostatic conditions (e.g. POTS, Long COVID, Syncope, Orthostatic Hypotension) to fluid management issues (e.g. Heart Failure and Sepsis). By giving patients and providers a real-time window into blood flow to the head, Lumia will improve the diagnosis and management of patients with these issues. Its wearable has been clinically demonstrated at institutions like Johns Hopkins and Duke, and they’re advancing toward FDA clearance for diagnostic use.

Conform Medical is revolutionizing cardiac arrhythmia treatment with its innovative Atlas 360 catheter, a soft-robotics breakthrough designed to overcome the limitations of current mapping and ablation methods. Its “one-size-fits-all” design, featuring inflatable polymer actuators, achieves an unprecedented greater than 90% electrode contact for rapid, whole-chamber mapping of complex arrhythmias like VTach and AFib in seconds, significantly reducing procedure time, cost, and patient risk. This streamlined approach eliminates the need for multiple catheter exchanges and is poised to capture a significant share of the rapidly expanding $10 billion cardiac arrhythmia market. Backed by proven preclinical safety and efficacy data, the Atlas 360 promises to transform electrophysiology practice, ensuring better patient outcomes and enhanced hospital efficiency.

In the spirit of transforming cardiovascular digital care, HRX has hosted a Pitch Competition since 2022 where early-stage innovators and start-ups showcased their breakthrough digital health innovations.

Learn more about the previous HRX Pitch Competition winners and where they are now.